Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Protein Page:
SRPK3 (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitylation
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
SRPK3 a CMGC protein kinase of the SRPK family. Exclusively expressed in skeletal and heart muscle. Two known splice variant isoforms. Note: This description may include information from UniProtKB.
Protein type: EC 2.7.11.1; Kinase, protein; Protein kinase, Ser/Thr (non-receptor); Protein kinase, CMGC; CMGC group; SRPK family
Chromosomal Location of Human Ortholog: Xq28
Molecular Function: protein binding
Reference #:  Q9UPE1 (UniProtKB)
Alt. Names/Synonyms: MGC102944; MSSK-1; MSSK1; Muscle-specific serine kinase 1; serine arginine rich protein-specific kinase 3; Serine/arginine-rich protein-specific kinase 3; serine/threonine kinase 23; Serine/threonine-protein kinase 23; Serine/threonine-protein kinase SRPK3; SFRS protein kinase 3; SR-protein-specific kinase 3; SRPK3; STK23
Gene Symbols: SRPK3
Molecular weight: 62,014 Da
Basal Isoelectric point: 6.83  Predict pI for various phosphorylation states
Select Structure to View Below

SRPK3

Protein Structure Not Found.


STRING  |  cBioPortal  |  Wikipedia  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  KinBase  |  Pfam  |  ENZYME  |  Phospho.ELM  |  NetworKIN  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment



 LTP 

LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 HTP 

HTP: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 S2‑p ______MsAstGGGG
0 1 S4‑p ____MsAstGGGGDS
0 1 T5‑p ___MsAstGGGGDSG
0 4 S50 MLQGLLGSDDEEQED
0 1 R78 IGDVFNGRYHVVRKL
0 1 R83 NGRYHVVRKLGWGHF
0 5 S330‑p GGARAGPsPASSSPA
0 2 S333 RAGPsPASSSPAPGG
0 4 S335 GPsPASSSPAPGGGR
0 13 T426‑p HFTEDIQtRQYRAVE
  mouse

 
S2 ______MSANAGGSG
N4 ____MSANAGGSGSV
A5 ___MSANAGGSGSVD
S49‑p LLQGLLGsDDEEQED
R77‑m1 IGDLFNGrYHVVrKL
R82‑m1 NGrYHVVrKLGWGHF
S328‑p EGTRAGPsPAsSsPV
S331‑p RAGPsPAsSsPVPGG
S333‑p GPsPAsSsPVPGGER
T424‑p HFTEDIQtRQYRAVE
  rat

 
S2 ______MSASAGGSG
S4 ____MSASAGGSGGM
A5 ___MSASAGGSGGMD
S49‑p LLQGLLGsDDEEQED
R77 IGDLFNGRYHVVRKL
R82 NGRYHVVRKLGWGHF
S325‑p EGTRAGPsPAsSsPV
S328‑p RAGPsPAsSsPVPTG
S330‑p GPsPAsSsPVPTGGE
T422 HFTEDIQTRQYRAVE
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.